Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Organ Preservation Market

ID: MRFR/HC/47706-HCR
200 Pages
Nidhi Mandole
April 2026

China Organ Preservation Market Research Report: Size, Share, Trend Analysis By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage),By Organ Type (Kidney, Liver, Heart, Lungs) and By End Users (Hospitals & Clinics, Organ Banks) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Organ Preservation Market Infographic
Purchase Options

China Organ Preservation Market Summary

As per Market Research Future analysis, the China Organ Preservation Market size was estimated at 25.5 USD Million in 2024. The Organ Preservation market is projected to grow from 27.56 USD Million in 2025 to 59.93 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.0% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China organ preservation market is experiencing robust growth driven by technological advancements and increasing demand for transplants.

  • Technological advancements in organ preservation methods are enhancing the viability of organs for transplantation.
  • The largest segment in the market is the preservation solutions segment, while the fastest-growing segment is the preservation devices segment.
  • Regulatory support and collaborative efforts among healthcare institutions are fostering innovation in the organ preservation landscape.
  • Key market drivers include increasing demand for transplants and government initiatives promoting organ donation awareness.

Market Size & Forecast

2024 Market Size 25.5 (USD Million)
2035 Market Size 59.93 (USD Million)
CAGR (2025 - 2035) 8.08%

Major Players

Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

China Organ Preservation Market Trends

The organ preservation market is currently experiencing notable growth, driven by advancements in preservation techniques and increasing demand for organ transplants. Innovations in preservation solutions and technologies are enhancing the viability of organs, thereby improving transplant success rates. This growth is further supported by a rising awareness of organ donation and transplantation, which is crucial in addressing the shortage of available organs. As healthcare systems evolve, the focus on improving organ preservation methods is becoming more pronounced, indicating a shift towards more efficient and effective practices. In addition, regulatory frameworks are adapting to support the development and implementation of new preservation technologies. This regulatory evolution is likely to foster a more conducive environment for research and development in the organ preservation market. Furthermore, collaborations between healthcare providers, research institutions, and technology companies are expected to drive innovation and improve preservation outcomes. Overall, the organ preservation market appears poised for continued expansion, reflecting a commitment to enhancing patient care and addressing critical healthcare challenges.

Technological Advancements

Recent innovations in preservation techniques are transforming the China Organ Preservation Market. New methods, such as machine perfusion and advanced preservation solutions, are enhancing organ viability and extending preservation times. These advancements are likely to improve transplant outcomes and increase the number of successful procedures.

Regulatory Support

The evolving regulatory landscape is playing a crucial role in shaping the organ preservation market. Government initiatives aimed at promoting organ donation and transplantation are fostering an environment conducive to the development of new preservation technologies. This support may lead to increased investment in research and development.

Collaborative Efforts

Collaboration among healthcare providers, research institutions, and technology firms is becoming increasingly important in the organ preservation market. These partnerships are expected to drive innovation, improve preservation techniques, and ultimately enhance patient outcomes in transplantation.

China Organ Preservation Market Drivers

Increasing Demand for Transplants

The rising incidence of organ failure in China is driving the demand for organ transplants, thereby propelling the organ preservation market. According to recent statistics, the number of patients requiring organ transplants has surged, with estimates suggesting a growth rate of approximately 10% annually. This increasing demand necessitates effective organ preservation techniques to ensure the viability of harvested organs. The organ preservation market is thus witnessing innovations aimed at enhancing preservation methods, which are crucial for successful transplant outcomes. As the population ages and lifestyle-related diseases become more prevalent, the urgency for effective organ preservation solutions is likely to intensify, further stimulating market growth.

Government Initiatives and Funding

The Chinese government is actively promoting organ donation and transplantation, which is positively impacting the organ preservation market. Initiatives aimed at increasing public awareness and improving the regulatory framework for organ donation are being implemented. Furthermore, government funding for research and development in organ preservation technologies is on the rise. This support is crucial for fostering innovation within the organ preservation market. With the government’s commitment to enhancing transplant success rates, the market is likely to see increased investment in advanced preservation techniques, which could lead to a more robust and efficient organ transplantation system in China.

Growing Awareness of Organ Donation

Public awareness regarding the importance of organ donation is gradually increasing in China, which is beneficial for the organ preservation market. Campaigns aimed at educating the population about the need for organ donors are gaining traction, leading to a rise in registered donors. This growing awareness is essential for ensuring a steady supply of organs for transplantation, thereby driving the demand for effective preservation methods. The organ preservation market is likely to see a corresponding increase in the development of preservation solutions that cater to the needs of a larger donor pool. As societal attitudes shift towards organ donation, the market may experience a significant boost in growth opportunities.

Advancements in Preservation Technologies

Technological innovations in organ preservation methods are significantly influencing the organ preservation market. Recent developments in hypothermic and normothermic preservation techniques have shown promise in extending the viability of organs outside the human body. For instance, the introduction of machine perfusion systems has been associated with improved outcomes in organ transplantation. The organ preservation market is expected to benefit from these advancements, as they not only enhance organ viability but also reduce the risk of transplant rejection. As hospitals and transplant centers in China increasingly adopt these technologies, the market is likely to experience substantial growth, with projections indicating a potential increase in market size by 15% over the next five years.

Collaboration Between Healthcare Institutions

Collaborative efforts among healthcare institutions, research organizations, and biotechnology firms are shaping the organ preservation market. These partnerships are focused on developing innovative preservation techniques and improving existing methods. By pooling resources and expertise, stakeholders are likely to accelerate advancements in the organ preservation market. Such collaborations can lead to the establishment of best practices and standardized protocols, which are essential for enhancing the efficiency of organ preservation. As more institutions in China engage in these collaborative initiatives, the market is expected to expand, with a potential increase in the adoption of cutting-edge preservation technologies.

Market Segment Insights

By Solution: Citrate Solution (Largest) vs. University of Wisconsin Solution (Fastest-Growing)

In the China organ preservation market, the distribution of market share among the various solutions reflects a diverse and competitive landscape. Citrate Solution currently represents the largest segment, appealing to a wide range of healthcare providers due to its effectiveness and reliability in preserving organs. Meanwhile, the University of Wisconsin Solution is gaining traction, highlighted by its superior performance and growing adoption rates among transplant surgeons, making it a formidable contender in this segment. Growth trends indicate a robust increase in demand for organ preservation solutions, driven by advancements in transplant technologies and increasing organ transplant procedures. The rise in awareness regarding the benefits of effective organ preservation is fueling the market further. Additionally, government support for organ transplant initiatives and innovations in preservation techniques are contributing significantly to the rapid adoption of emerging solutions like the University of Wisconsin Solution, positioning it as a key player in this dynamic market.

Citrate Solution (Dominant) vs. University of Wisconsin Solution (Emerging)

Citrate Solution has established itself as a dominant force in the organ preservation segment, prized for its ability to enhance organ viability and function during transportation. Its formulation is specifically designed to reduce cellular metabolism, offering a protective effect that prolongs the lifespan of organs outside the body. In contrast, the University of Wisconsin Solution, though emerging, has quickly gained favor among medical professionals for its unique composition that optimally preserves kidney function, especially in deceased donor transplants. This solution is known for its effectiveness in minimizing ischemic damage, making it central to discussions about future advancements in preservation methods. As transplant rates increase, both solutions will play critical roles, albeit with Citrate Solution leading the current market share.

By Preservation Techniques: Static Cold Storage (Largest) vs. Dynamic Cold Storage (Fastest-Growing)

In the China organ preservation market, Static Cold Storage holds the largest market share due to its established use and reliability in preserving organs for transplantation. This method has become the foundational technique in many hospitals and organ transplant centers, demonstrating its efficacy and broad acceptance. On the other hand, Dynamic Cold Storage is gaining traction, appealing to institutions looking for advanced preservation solutions that ensure better outcomes for organ viability.

Preservation Techniques: Static Cold Storage (Dominant) vs. Dynamic Cold Storage (Emerging)

Static Cold Storage is characterized by its ability to maintain organs at low temperatures using a consistent low-temperature environment, which has been traditionally effective in preventing organ deterioration. Its long-standing presence in the China organ preservation market has instilled confidence among medical professionals. Conversely, Dynamic Cold Storage represents a forward-looking approach, utilizing controlled perfusion techniques to optimize organ preservation. This emerging technology is seen as vital for enhancing organ viability, and its adoption is rapidly growing as healthcare facilities seek to improve transplant success rates and respond to increasing organ demand.

By Organ Type: Kidney (Largest) vs. Liver (Fastest-Growing)

The organ preservation market is distinctly segmented with the Kidney leading in market share, indicating a strong demand from transplant centers and hospitals prioritizing renal transplants. This dominance in the segment reflects the high incidence of kidney-related diseases and the growing number of patients requiring renal replacement therapies. On the other hand, the Liver segment shows considerable growth, reflecting advancements in preservation techniques and increasing awareness among healthcare providers about the importance of effective liver transplant programs. Growth trends within the organ preservation segment are influenced by several factors, including advancements in preservation technology, increased investment in research, and rising incidences of organ failure. The Liver segment is experiencing robust growth due to innovations in storage solutions and a rise in liver transplant procedures. Additionally, regulatory approvals for new preservation techniques are driving both segments, as healthcare providers seek to enhance organ viability and improve patient outcomes.

Kidney (Dominant) vs. Lungs (Emerging)

The Kidney segment is characterized by its established market position, driven by a high volume of transplants and supportive healthcare infrastructure dedicated to renal care. It is often viewed as the backbone of organ preservation efforts due to its significant role in alleviating chronic kidney disease. In contrast, the Lungs segment represents an emerging opportunity within the market, as it is less developed but showing promise due to increased focus on treating pulmonary conditions. Advances in lung preservation technology, alongside increasing recognition of the need for lung transplants, mark a shift towards a more structured approach to lung preservation in clinical settings.

By End-User: Hospitals & Clinics (Largest) vs. Organ Banks (Fastest-Growing)

In the China organ preservation market, the end-user segment is primarily divided between hospitals & clinics and organ banks. Hospitals and clinics hold the largest share, driven by their critical role in organ transplantation and the urgent need for effective preservation solutions. Organ banks, while smaller in terms of market share, are experiencing significant growth due to increasing awareness and advancements in preservation technologies. The growth trends within the end-user segment are influenced by several factors, including rising organ transplantation rates and the expansion of organ donation programs. Hospitals and clinics are continually seeking innovative solutions for preservation to enhance organ viability and improve patient outcomes. Meanwhile, organ banks are rapidly evolving, with a focus on developing more efficient preservation methods that cater to the needs of healthcare providers and patients alike, contributing to their status as the fastest-growing segment.

Hospitals & Clinics (Dominant) vs. Organ Banks (Emerging)

Hospitals and clinics, being the dominant end-users in the China organ preservation market, are equipped with advanced medical technology and protocols for organ handling. These entities prioritize reliable preservation solutions to ensure optimal organ viability for transplant procedures. They often partner with specialists to enhance preservation techniques and thus improve overall transplant success rates. On the other hand, organ banks represent an emerging segment, showing promising growth as they focus on innovation in preservation methods. They play a vital role in the supply chain by ensuring the availability of preserved organs for transplantation. Organ banks are increasing their collaboration with hospitals and research institutions to develop new technologies that enhance preservation efficacy, thus gaining a stronger foothold in the market.

Get more detailed insights about China Organ Preservation Market

Key Players and Competitive Insights

The organ preservation market is currently characterized by a dynamic competitive landscape, driven by advancements in technology and increasing demand for organ transplants. Key players are focusing on innovation and strategic partnerships to enhance their operational capabilities. For instance, Organ Recovery Systems (US) has positioned itself as a leader in the development of preservation solutions that extend organ viability, while TransMedics (US) emphasizes its cutting-edge organ perfusion technology, which is pivotal in improving transplant outcomes. Similarly, Xvivo Perfusion (SE) is known for its innovative approaches to organ preservation, particularly in the realm of lung and heart transplants, indicating a trend towards specialization among competitors. Collectively, these strategies contribute to a competitive environment that is increasingly focused on technological advancement and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the organ preservation market appears moderately fragmented, with several key players exerting influence over their respective niches. This fragmentation allows for a variety of approaches to organ preservation, fostering innovation while also creating challenges in terms of market share and customer loyalty.

In October Paragonix Technologies (US) announced a strategic partnership with a leading transplant center to enhance the adoption of its organ preservation devices. This collaboration is expected to facilitate clinical trials and expand the reach of Paragonix's innovative solutions, thereby solidifying its market position. The strategic importance of this partnership lies in its potential to accelerate the integration of advanced preservation technologies into clinical practice, ultimately improving patient outcomes.

In September Bridge to Life (US) launched a new preservation solution aimed at increasing the viability of organs during transport. This product introduction is significant as it addresses a critical challenge in organ transplantation, namely the time-sensitive nature of organ viability. By enhancing the preservation process, Bridge to Life is likely to strengthen its competitive edge and appeal to transplant centers seeking reliable solutions.

In August Tissue Regenix (GB) expanded its operations into the Asian market, focusing on the growing demand for organ preservation technologies in that region. This strategic move is indicative of a broader trend towards geographical expansion among key players, as companies seek to tap into emerging markets with increasing healthcare needs. The implications of this expansion could be profound, as it may lead to increased competition and innovation in the organ preservation sector.

As of November current trends in the organ preservation market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into preservation technologies. Strategic alliances are becoming increasingly important, as companies recognize the value of collaboration in enhancing their technological capabilities. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability. This shift suggests that companies that prioritize research and development, alongside strategic partnerships, will be better positioned to thrive in an increasingly competitive landscape.

Key Companies in the China Organ Preservation Market include

Industry Developments

Recent developments in the China Organ Preservation Market highlight significant advancements and collaborations among key players. In June 2023, United Therapeutics Corporation announced a strategic partnership with Beijing Shijitan Hospital to enhance organ preservation processes, aiming to improve organ viability for transplantation.

Research initiatives have ramped up at Xi'an Jiaotong University as they unveiled a new cryopreservation technology that holds promise for better organ recovery rates. Additionally, Wuxi Apptec has expanded its capabilities to provide enhanced logistic solutions for organ transportation, integrating innovative preservation techniques to better serve hospitals nationwide.

Jiangsu University and Zhejiang University continue to contribute through collaborative Research and Development efforts focusing on long-term organ storage methodologies. Notably, there have been discussions surrounding mergers; however, as of October 2023, no substantial acquisition activity has been publicly disclosed within the specific companies of interest.

Overall, the market is witnessing a surge in technological advancements and academic collaborations, strengthening the foundation for future growth in organ preservation techniques across China.

Future Outlook

China Organ Preservation Market Future Outlook

The Organ Preservation Market in China is projected to grow at 8.08% CAGR from 2025 to 2035, driven by technological advancements and increasing organ transplant demand.

New opportunities lie in:

  • Development of advanced preservation solutions with extended shelf life.
  • Implementation of AI-driven logistics for organ transport efficiency.
  • Partnerships with hospitals for integrated organ preservation services.

By 2035, the organ preservation market is expected to achieve substantial growth and innovation.

Market Segmentation

China Organ Preservation Market End-User Outlook

  • Hospitals & Clinics
  • Organ Banks

China Organ Preservation Market Solution Outlook

  • University of Wisconsin Solution
  • Custodial HTK
  • Collins Solution
  • Celsior Solution
  • Perfadex
  • Citrate Solution

China Organ Preservation Market Organ Type Outlook

  • Kidney
  • Liver
  • Heart
  • Lungs

China Organ Preservation Market Preservation Techniques Outlook

  • Static Cold Storage
  • Dynamic Cold Storage

Report Scope

MARKET SIZE 2024 25.5(USD Million)
MARKET SIZE 2025 27.56(USD Million)
MARKET SIZE 2035 59.93(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.08% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Organ Recovery Systems (US), TransMedics (US), Xvivo Perfusion (SE), LifeLink Foundation (US), Tissue Regenix (GB), Paragonix Technologies (US), Bridge to Life (US), Preservation Solutions (US)
Segments Covered Solution, Preservation Techniques, Organ Type, End-User
Key Market Opportunities Advancements in preservation techniques enhance organ viability, driving demand in the organ preservation market.
Key Market Dynamics Technological advancements in organ preservation techniques drive competitive dynamics and regulatory adaptations in the market.
Countries Covered China
Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Garvit Vyas LinkedIn
Vice President - Operations
Garvit Vyas is a Research Analyst with experience in working across multiple industry domains in the market research sector. Over the past four years, he has been actively involved in analyzing diverse markets, gathering industry insights, and contributing to the development of comprehensive research reports. His work includes studying market trends, evaluating competitive landscapes, and supporting data-driven business insights. In the early phase of his career, Garvit worked on cross-domain research projects, which helped him build a strong foundation in market analysis, data interpretation, and industry intelligence across various sectors. Later, he transitioned into the Quality Control (QC) function, where he focuses on reviewing and refining research reports and marketing collaterals to ensure accuracy, consistency, and high editorial standards. His responsibilities include validating research data, improving report structure, and maintaining the overall quality of published content. Garvit is committed to maintaining strong research integrity and delivering reliable insights that support informed business decision-making.
Leave a Comment

FAQs

What is the current valuation of the organ preservation market in China as of 2024?

The organ preservation market in China was valued at $25.5 Million in 2024.

What is the projected market valuation for the organ preservation market in China by 2035?

The market is projected to reach $59.93 Million by 2035.

What is the expected CAGR for the organ preservation market in China during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 8.08%.

Which organ types are leading in market valuation within the organ preservation sector in China?

The leading organ types include Liver at $7.6 Million, Kidney at $5.1 Million, Heart at $6.4 Million, and Lungs at $6.4 Million.

What are the key preservation techniques utilized in the organ preservation market in China?

Key preservation techniques include Static Cold Storage valued at $10.5 Million and Dynamic Cold Storage at $15.0 Million.

Which solutions are most commonly used in the organ preservation market in China?

Common solutions include University of Wisconsin Solution at $5.1 Million, Custodial HTK at $4.5 Million, and Collins Solution at $3.8 Million.

Who are the major players in the organ preservation market in China?

Major players include Organ Recovery Systems, TransMedics, Xvivo Perfusion, and LifeLink Foundation.

What is the market valuation for hospitals and clinics as end-users in the organ preservation market in China?

The market valuation for hospitals and clinics as end-users was $15.3 Million.

How does the market valuation for organ banks compare to hospitals and clinics in China?

The market valuation for organ banks was $10.2 Million, which is lower than that of hospitals and clinics.

What trends are expected to shape the organ preservation market in China by 2035?

Trends may include advancements in preservation technologies and increased demand for organ transplants, driving market growth.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions
%>